Inflammatory Arthritis Disability: QOL & Work Impact Guide

NP Chronicles · Clinical Deep-Dive

When Function Fails: What Two New Studies Tell Us About Disability, Quality of Life, and Work in Inflammatory Arthritis

A real-world look at how HAQ-DI functional decline translates into lost quality of life and lost paychecks — and why occupation type may matter as much as diagnosis.

CLINICAL PRACTICE • RHEUMATOLOGY • FUNCTIONAL ASSESSMENT • BOARD PREP INSIDE

Two new inflammatory arthritis studies, one from a large Canadian registry and one from a national UK audit, put hard numbers behind something clinicians have long suspected: functional decline doesn't wait for "severe" disease to start costing patients their quality of life and their jobs.

For NPs managing rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA), the Health Assessment Questionnaire Disability Index (HAQ-DI) is a familiar tool — but it's easy to treat it as a research instrument rather than a clinical trigger. These two studies argue it should be the latter.

Study 1: The Rheum4U Registry — Disability Has a Tipping Point

Researchers from the University of Calgary's Rheum4U Precision Health Registry followed 1,177 adults with inflammatory arthritis (58% RA, 25% axSpA, 17% PsA) and compared their HAQ-DI functional disability level against two outcomes: health-related quality of life (EQ-5D-5L) and work/activity productivity (WPAI).

HAQ-DI scores were split into four familiar categories:

Category	HAQ-DI Range	% of Cohort
No disability	0	29.9%
Mild-to-moderate	>0–1	47.3%
Moderate-to-severe	1–2	18.9%
Severe-to-very-severe	2–3	3.9%

The headline finding: quality of life and productivity didn't decline gently. Patients with no disability reported quality-of-life scores roughly on par with the general Canadian population. But once patients crossed into mild-to-moderate disability, their scores were already worse than some patients living with diabetes or COPD. By moderate-to-severe disability, quality of life had dropped to levels comparable to chronic kidney disease and multiple sclerosis.

Work outcomes followed a similar but distinct pattern. Presenteeism (reduced productivity while still at work) and overall work impairment rose steadily with each disability level. Absenteeism, though, stayed low until the severe-to-very-severe category, where it jumped sharply. In other words: most patients don't stop showing up to work as they decline — they show up and struggle, often silently, long before they take sick leave.

Clinical Bottom Line Moderate-to-severe disability (HAQ-DI 1–2) is the critical inflection point where quality-of-life and productivity losses become clinically meaningful and exceed established minimum important difference thresholds. Don't wait for a HAQ-DI of 2+ to escalate care — the damage is often already done by the time a patient crosses HAQ-DI 1.

Why the Decline Isn't a Straight Line

One of the more clinically useful nuances: EQ-5D-5L utility scores (the preference-weighted "how good is this health state" measure) dropped disproportionately at the most severe disability level, while the simpler visual analogue scale (VAS, "rate your health 0–100") declined in a straighter line. That's a measurement property difference, not a biological one — utility scoring weights multiple domains (mobility, self-care, pain, anxiety/depression) multiplicatively, so accumulating problems compound. It's a good reminder that different PROMs answer subtly different questions, and relying on just one can under- or overstate severity.

Case From Practice A 52-year-old woman with seropositive RA, on methotrexate monotherapy, reports her joints are "manageable" and declines escalation. Her HAQ-DI comes back at 1.1 — freshly into moderate-to-severe territory. She hasn't missed a shift at her retail management job in months. Based on this data, that HAQ-DI score alone predicts a meaningful hit to her quality of life and a real (if invisible) productivity loss at work, even though her attendance looks fine. This is exactly the patient who benefits from a treat-to-target conversation now, not after she starts calling in sick.

Study 2: NEIAA — Not All Jobs Absorb Disability Equally

The second study, from the UK's National Early Inflammatory Arthritis Audit (NEIAA), followed over 12,000 newly diagnosed patients and asked a different question: does occupation type change how inflammatory arthritis affects work?

The answer was a clear yes. At diagnosis, nearly one in five patients had already stopped working or changed jobs because of their arthritis — often before formal diagnosis, given a median symptom duration of just three months. But the burden wasn't evenly distributed. Compared with higher managerial and professional workers, people in routine, semi-routine, small-business, and lower-supervisory/technical occupations were more than twice as likely to have stopped working, and reported significantly higher presenteeism and overall work impairment.

Absenteeism was the one outcome that showed no difference across occupational class — a useful reminder that absenteeism alone is a poor proxy for the true burden of disease, since eligibility for paid sick leave, workplace culture, and caregiving responsibilities all shape whether someone actually takes time off.

Nuance Worth Noting Gender differences cut in an unexpected direction here: women were less likely than men to stop working outright, but reported significantly higher presenteeism — meaning they were more likely to keep working while substantially impaired. If you're only screening for "are you still employed?", you may be missing the population absorbing the most silent functional cost.

Why This Matters for Your Practice Setting

If your patient panel includes workers in physically demanding, less flexible jobs (manual labor, retail, food service, skilled trades), assume their functional threshold for work disruption is lower than a desk-based professional with the same joint counts and labs. The occupational disparity findings suggest these patients need earlier referral to occupational therapy and more proactive conversations about workplace accommodations — not because their disease is more severe, but because their job has less room to absorb it.

Board Prep Corner

HAQ-DI scoring: Range 0–3, assessing 8 domains (dressing/grooming, arising, eating, walking, hygiene, reach, grip, other activities). Categories: no disability (0), mild-to-moderate (>0–1), moderate-to-severe (1–2), severe-to-very-severe (2–3).

WPAI domains (know all four): Absenteeism (work time missed), Presenteeism (reduced productivity while working), Overall Work Impairment (combines both), Activity Impairment (limits on unpaid daily activities). All scored 0–100%, higher = worse.

CDAI (Clinical Disease Activity Index): Range 0–76. Remission ≤2.8, Low >2.8–10, Moderate >10–22, High >22. Used for RA and PsA; not routinely applied in axSpA.

EQ-5D-5L: Five domains (mobility, self-care, usual activities, pain/discomfort, anxiety/depression), each rated on a 5-point severity scale. Canadian value set utility ranges from −0.148 (worse than death) to 0.949 (perfect health); VAS ranges 0–100.

Test-writer trap: A question may imply that low absenteeism means low disease burden. Both studies show this is false — presenteeism and activity impairment rise well before absenteeism does.

Practice Takeaways

• Use HAQ-DI as an escalation trigger, not just a documentation exercise — a score crossing into the 1–2 range warrants a treat-to-target conversation even if the patient reports feeling "okay."
• Ask about presenteeism directly ("Are you getting through your work the way you used to, even if you're still going in?") rather than relying on attendance records alone.
• Factor occupation type into your index of suspicion and referral threshold — physically demanding, inflexible jobs deserve earlier OT and vocational support referrals.
• Remember that quality-of-life instruments (utility vs. VAS) can tell different stories at the same disability level; don't anchor on a single number.

Quick Board-Prep Quiz

1. A patient's HAQ-DI score is 1.4. Which functional disability category does this fall into?

Moderate-to-severe disability spans HAQ-DI 1–2, so a score of 1.4 falls squarely in this category — the threshold the Rheum4U study identified as a critical inflection point for quality-of-life and productivity loss.

2. Which WPAI domain showed no significant difference across occupational classes in the NEIAA study?

Absenteeism was comparable across occupational groups, while presenteeism and overall work impairment were significantly higher in routine, semi-routine, and lower-supervisory occupations compared with higher managerial/professional workers.

3. In the Rheum4U study, which HRQoL measure declined disproportionately at the most severe disability level rather than in a linear fashion?

The EQ-5D-5L utility score, derived from a multi-attribute preference-weighted algorithm, showed a disproportionately larger drop at the severe-to-very-severe level. The VAS, a simple linear 0–100 self-rating, declined more evenly across categories.

FAQ

What HAQ-DI score should prompt a treatment escalation discussion? +

While treat-to-target decisions rest on composite disease activity measures like CDAI, this real-world data suggests that a HAQ-DI crossing into the moderate-to-severe range (1–2) coincides with clinically meaningful drops in quality of life and productivity that exceed minimum important difference thresholds — making it a reasonable clinical cue to reassess the treatment plan, not just a research metric to log.

Is absenteeism a reliable way to screen for work-related disease burden in inflammatory arthritis? +

No. Both studies found absenteeism rose only at the most severe disability levels and showed no meaningful difference across occupational classes, while presenteeism and activity impairment increased much earlier and more consistently. Relying on attendance alone will miss a substantial portion of functional burden.

Does occupation type affect work outcomes in inflammatory arthritis independent of disease severity? +

Yes. The NEIAA audit found that after adjusting for age and sex, people in routine, semi-routine, small-business, and lower-supervisory/technical occupations had more than twice the odds of stopping work compared with higher managerial or professional workers, along with higher presenteeism and overall work impairment.

What's the difference between EQ-5D-5L utility and VAS scores? +

The utility score is derived from five weighted health domains (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) converted into a single preference-based value using population value sets, ranging from below zero (worse than death) to just under 1 (perfect health). The VAS is a simple patient self-rating of overall health from 0 to 100. They can behave differently across disease severity, as seen in this data.

• Fuhrmann AC, Mosher DP, Benseler SM, Ocampo W, Larchée MJ, Marshall DA, on behalf of the Rheum4U Precision Health Registry. From disability to daily life: functional status, quality of life and work productivity in real-world inflammatory arthritis. Rheumatology 2026;65(7):keag300.
• Bechman K, Cook ES, Alveyn E, Houssien A, Stevens M, Russell MD, Adas M, Amlani-Hatcher P, Norton S, Lempp H, Ledingham JM, Galloway JB, Walker-Bone K. Occupational impacts of early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit. Rheumatology 2024;63(7):1856–1867.

NP Chronicles © Clinical education for NP students and new graduates. This content is for educational purposes and does not replace individualized clinical judgment.